Showing results (281-290 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|May 21, 2025
RGN6024 is a brain-penetrant, small molecule tubulin destabilizer for the treatment of glioblastomaLilian A Patrón, Helen Yeoman, Joseph Ramos, et al.
Molecular Cancer Therapeutics|February 11, 2026
Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing SarcomaNenggang Zhang, Mary Perez, Gaye N Jenkins, et al.
Molecular Cancer Therapeutics|February 9, 2026
Microsatellite instable cancer cells acquire on-target resistance mutations to WRN helicase inhibitorsFaith Fowler, Jessica Gajda, Amirhossein Mafi, et al.
Molecular Cancer Therapeutics|January 24, 2026
DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responsesVinicio A Melo Gallegos, Shirley Greenwald, Ami Tamir, et al.
Molecular Cancer Therapeutics|March 26, 2025
Therapeutic Targeting of BET proteins in SarcomaNiknam Riyahi, Rada Malko, Harlan E Shannon, et al.
Molecular Cancer Therapeutics|March 25, 2025
Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient GlioblastomaHumeyra Kaanoglu, Adebimpe Adefolaju, Casey Fraley, et al.
Molecular Cancer Therapeutics|March 25, 2025
Epigenetic Regulation of Cellular Senescence in Gastrointestinal CancerTing Ye, Hang Gao, Zheng-Rong Zhang, et al.
Molecular Cancer Therapeutics|March 19, 2025
CD24-targeted CAR-T cells mediated long-term anti-tumor efficacy through activation of endogenous tumor immune responsesYong Huang, Xiao Yang, Jing Li, et al.
Molecular Cancer Therapeutics|March 19, 2025
Histotripsy-focused ultrasound treatment abrogates tumor hypoxia responses and stimulates anti-tumor immune responses in melanomaBrian Song, Heineken Queen, Sarah F Ferris, et al.
Pageof 601